The Coronavirus Vaccine Manufacturing Failures of Emergent Biosolutions - GOVPUB-Y4_OV2-PURL-gpo183446 | Content Details | GovInfo

Skip to main content

Start of main content

The Coronavirus Vaccine Manufacturing Failures of Emergent Biosolutions

Summary

Branch: Legislative

Category: Congressional Committee Materials

SuDoc Class Number: Y 4.OV 2:C 81/4

Government Author: Congress, House of Representatives, Committee on Oversight and Reform

Publication Title: The Coronavirus Vaccine Manufacturing Failures of Emergent Biosolutions

Date Issued: 2022

Subject: Coronavirus infections
COVID-19 (Disease)
Development
Government policy
Prevention
Standards
Subsidies
Treatment
Vaccination
Vaccines
Vaccines industry
United States

Content Origin: This content was harvested from online sources of the original hosting or authoring agency and may not reflect current policy. As Federal agencies add publications to their websites, or report new publications to GPO per statutory mandate (44 U.S.C. §§ 1710, 1902-1903), GPO ensures long-term preservation of and access to the content.